The Global Patent Exchange

Web: www.tynax.com |  Phone: (650)292-4849 |  Email: contact@tynax.com

Patent for Sale:

Technology to treat cancer using combinations of weak electromagnetic fields    

Effects on cell morphology can be modulated by varying the applied magnetic field, demonstrating that variation in the applied fields can further modulate the efficacy of exposure upon cells

Overview

A novel technology to treat cancer using combinations of weak electromagnetic fields (EMFs). Weak EMFs are generally considered ‘safe’ and have little or no effect on healthy cells. Research has shown that using combinations of low frequency modulated microwave (GHz) and high frequency (MHz) magnetic fields levels of a critical cancer marker protein can be reduced. This builds upon technology from those who have a product in-market using a single modulated field

Primary Application of the Technology

Cancer affects 1 in 3 people during their lifetime and remains one of the largest causes of death globally. BUPA estimates UK treatment costs to rise 50% over the next decade from £9.4 billion (2010) to £15.3 billion with an average cost of £40,000 per person. Many recently approved drugs for cancer treatment in the US have costs in the region of £10,000 per month. Conventional treatments (chemotherapies and radiotherapies) damage normal tissue as well as cancer cells, leading to severe side-effects through treatment. New alternate therapies are needed with lower side-effects and better targeting of cancer cells.

How the Technology Solves the Problem

Ornithine decarboxylase is a protein needed for cells to divide and is up-regulated in 90% of cancers (Auvinen et al. Nature 360, 355-358). It is seen both as a cancer marker and a potential therapeutic target. Combinations of modulated microwave and high-frequency magnetic fields reduce ODC levels further than seen by either field on its own. This demonstrates an enhanced effect, and the basis of the patented technology.

L929 fibroblast cells exposed to combinations of microwave (M) and high-frequency magnetic (Hf) fields show a non-additive reduction in ODC when both fields are applied. Further work shows effects on cell morphology that can be modulated by varying the applied magnetic field. This demonstrates that variation in the applied fields can further modulate the efficacy of exposure upon cells. Comparison of cell length / width vs cell size for control cells (black) and two different modulations of the magnetic field (blue and red). This shows the cell morphology is effected by the modulation of the applied field, evidencing a different response of the cells to the applied field.

The seller may consider selling these patents individually.

Patent Summary

U.S. Patent Classes & Classifications Covered in this listing:

Class 600: Surgery

Subclass 9: MAGNETIC FIELD APPLIED TO BODY FOR THERAPY

View this listing on the Tynax website: www.tynax.com/listing/5801